Home › Schizophrenia
Pag-aaral pangklinika para sa Schizophrenia na nagre-recruit sa U.S.
105 pag-aaral para sa Schizophrenia ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Atlanta, GA22 pag-aaral
- Chicago, IL20 pag-aaral
- Little Rock, AR19 pag-aaral
- Hollywood, FL15 pag-aaral
- Boston, MA14 pag-aaral
- San Diego, CA13 pag-aaral
- Houston, TX13 pag-aaral
- New York City, NY13 pag-aaral
- Hialeah, FL13 pag-aaral
- Austin, TX13 pag-aaral
- Garden Grove, CA12 pag-aaral
- Germantown, MD11 pag-aaral
- Miami, FL10 pag-aaral
- Camden, NJ10 pag-aaral
- Richardson, TX9 pag-aaral
- Los Angeles, CA8 pag-aaral
- Anaheim, CA8 pag-aaral
- Inglewood, CA8 pag-aaral
- Cincinnati, OH8 pag-aaral
- Johns Creek, GA8 pag-aaral
- Grand Prairie, TX8 pag-aaral
- El Cajon, CA8 pag-aaral
- Dallas, TX8 pag-aaral
- Philadelphia, PA8 pag-aaral
- Cambridge, MA8 pag-aaral
- Pittsburgh, PA7 pag-aaral
- Springdale, AR7 pag-aaral
- West Palm Beach, FL7 pag-aaral
- Staten Island, NY7 pag-aaral
- Las Vegas, NV7 pag-aaral
- St. Louis, MO7 pag-aaral
- New Haven, CT6 pag-aaral
- Queens, NY6 pag-aaral
- Chino, CA6 pag-aaral
- Orlando, FL6 pag-aaral
- Nashville, TN6 pag-aaral
- The Bronx, NY6 pag-aaral
- Richmond, VA6 pag-aaral
- Downey, CA6 pag-aaral
- Riverside, CA6 pag-aaral
Ayos sa estado
- Alabama4 pag-aaral
- Arizona4 pag-aaral
- Arkansas21 pag-aaral
- California44 pag-aaral
- Colorado3 pag-aaral
- Connecticut9 pag-aaral
- Florida26 pag-aaral
- Georgia29 pag-aaral
- Illinois25 pag-aaral
- Maryland17 pag-aaral
- Massachusetts22 pag-aaral
- Michigan5 pag-aaral
- Minnesota4 pag-aaral
- Mississippi3 pag-aaral
- Missouri10 pag-aaral
- Nebraska6 pag-aaral
- Nevada7 pag-aaral
- New Jersey13 pag-aaral
- New York23 pag-aaral
- North Carolina3 pag-aaral
- Ohio18 pag-aaral
- Oklahoma4 pag-aaral
- Pennsylvania15 pag-aaral
- Tennessee6 pag-aaral
- Texas34 pag-aaral
- Virginia6 pag-aaral
- Washington8 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
Nagre-recruitPhase 3
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07686263A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia
Nagre-recruitPhase 1
Edad 18 hanggang 55 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07615426Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia
Nagre-recruitPhase 3
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07227818NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
Nagre-recruitPhase 3
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07114874Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
Nagre-recruitPhase 3
Edad 5 hanggang 17 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06229210NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
Nagre-recruitPhase 3
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07105098Study to Evaluate the Safety and Efficacy of Ublituximab in Participants With Schizophrenia
Nagre-recruitPhase 2
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07680946State Representation in Early Psychosis 2
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 15 hanggang 45 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07834203A Study of Brenipatide in Adult Participants With Schizophrenia
Nagre-recruitPhase 2
Edad 18 hanggang 55 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07410507A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
Nagre-recruitPhase 3
Edad 5 hanggang 17 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07424404A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
Nagre-recruitPhase 4
Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT07105111A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
Nagre-recruitPhase 1
Edad 18 hanggang 55 · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07734493Circuitry-Guided Smoking Cessation in Schizophrenia (UH3)
Nagre-recruit
Edad 22 hanggang 65 · Lahat ng kasarian · Na-update Set 16, 2026 · NCT05276050A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT0714591852-week Open Label Safety-Tolerability Study
Nagre-recruitPhase 3
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07369154A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
Nagre-recruitPhase 3
Edad 13 hanggang 17 · Lahat ng kasarian · Na-update Set 4, 2026 · NCT07288567Genetic Basis of the Risk and Consequences of Cannabis Exposure in Humans
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 21 hanggang 60 · Lahat ng kasarian · Na-update Set 2, 2026 · NCT06058702A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT
Nagre-recruitPhase 1
Edad 18 hanggang 55 · Lahat ng kasarian · Na-update Set 2, 2026 · NCT07061288A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT07459647Overnight Thalamic TES-TI to Modulate Sleep Spindles in Individuals With Schizophrenia Spectrum Disorders and Matched Healthy Controls
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 50 · Lahat ng kasarian · Na-update Ago 31, 2026 · NCT07680114Activities to Change Your Mood: A Test of the Acceptability and Initial Efficacy in Clinical Samples and Healthy Controls
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Ago 31, 2026 · NCT06911723Cerebellar Modulation of Cognition in Psychosis
Nagre-recruit
Edad 18 hanggang 55 · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT06107764Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT07101094Enhancing Veteran-Clinical Collaboration in VA PRRCs
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT06898879Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT07379827Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.